Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Biol ; 61(1): 12-22, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36524765

ABSTRACT

CONTEXT: Intervertebral disc degeneration (IDD) is the pathological basis of spinal degenerative diseases. Puerarin (PU) is an isoflavonoid with functions and medicinal properties. OBJECTIVE: To explore the effect of PU on IDD and its potential mechanism of action. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were divided into sham, IDD, low PU, and high PU groups. Rat nucleus pulposus cells (NPCs) were isolated and divided into control, IL-1ß, 100 and 200 µmol/mL PU, TAK-242 (TLR4 inhibitor), or 200 µmol/mL PU + LPS (TLR4 activator) groups. The water content, inflammatory factors, proliferation activity, TLR4/NF-κB pathway activity, apoptosis rate, protein expression of apoptosis, and histology of the extracellular matrix (ECM) were analysed. RESULTS: In vivo: Compared with the IDD group, disorganization of intervertebral disc tissue was significantly improved, water content (2.80 ± 0.24 mg, 3.91 ± 0.31 mg vs. 2.02 ± 0.21 mg) and expression levels of collagen II and aggrecan were significantly increased, and the levels of inflammatory factors and the expression levels of TLR4, MyD88, and p-p65 were significantly decreased in IDD rats treated with PU. In vitro: Compared with the IL-1ß group, the proliferation activity of IL-1ß-treated NPCs and the expression of collagen II and aggrecan were significantly increased, while the apoptosis rate, levels of inflammatory factors, and the expression levels of TLR4, MyD88, and p-p65 were significantly decreased in IL-1ß-treated NPCs treated with PU. LPS reversed the biological function changes of IL-1ß-treated NPCs induced by PU. CONCLUSIONS: PU can delay the progression of IDD by inhibiting activation of the TLR4/NF-κB pathway.


Subject(s)
Intervertebral Disc Degeneration , Nucleus Pulposus , Rats , Animals , Nucleus Pulposus/metabolism , Nucleus Pulposus/pathology , Intervertebral Disc Degeneration/drug therapy , Intervertebral Disc Degeneration/metabolism , Intervertebral Disc Degeneration/pathology , NF-kappa B/metabolism , Aggrecans/metabolism , Aggrecans/pharmacology , Myeloid Differentiation Factor 88 , Lipopolysaccharides/pharmacology , Toll-Like Receptor 4/metabolism , Rats, Sprague-Dawley , Apoptosis , Collagen/metabolism , Water/pharmacology
2.
Int Immunopharmacol ; 87: 106833, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32739831

ABSTRACT

BACKGROUND: Osteoporosis (OP) is a common inflammatory disease. The goal of this study was to investigate the effect of IL-1R1 and IL-1RN polymorphisms on OP predisposition among the Chinese Han population. METHODS: Six single nucleotide polymorphisms (SNPs) in IL-1R1 and IL-1RN were genotyped using the Agena MassARRAY platform in 594 OP patients and 599 age- and sex- matched healthy controls. Logistic regression analysis was used to calculate odds ratios (OR) and 95% confidence intervals (CI). Multifactor dimensionality reduction (MDR) analysis was used to analyze SNP-SNP interaction. The correlations of genotypes with clinical variables were evaluated using analysis of covariance (ANOVA). RESULTS: Overall, IL-1R1 rs3917225 (OR = 1.40, 95% CI: 1.10-1.80, p = 0.007) was associated with a higher risk for OP, while IL-1RN rs17042888 (OR = 0.55, 95% CI: 0.34-0.90, p = 0.016) was associated with a lower risk. Specifically, the risk association between these polymorphisms and OP risk might be related to age, sex and BMI. Furthermore, rs10490571, rs17042888, rs3181052 and rs452204 were associated with the T scores of the lumbar spine or total hip. CONCLUSION: This study is the first to find that rs10490571, rs956730 and rs3917225 in IL-1R1 and rs17042888 in IL-1RN may be genetic contributors to OP susceptibility among the Chinese Han population. Our findings increase the understanding of the role of IL-1R1 and IL-1RN in the genetic etiology of osteoporosis. Nevertheless, these results should be confirmed in larger cohorts.


Subject(s)
Asian People/genetics , Interleukin 1 Receptor Antagonist Protein/genetics , Osteoporosis/genetics , Receptors, Interleukin-1 Type I/genetics , Adult , Aged , Female , Genetic Predisposition to Disease , Genotype , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide
SELECTION OF CITATIONS
SEARCH DETAIL
...